Please assess the completion status of the following clinical trial:

Trial Title: Effect of Epidermal Growth Factor Receptor Inhibitors on Magnesium Homeostasis in Patients With Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of malignancy~  * Planning to receive therapy with an inhibitor of the EGFR pathway (either on or off a clinical trial and may be monotherapy or combined with other therapies)~* Normal serum magnesium level~Exclusion Criteria:~* Glomerular filtration rate ≥ 60 mL/min~* No severe underlying renal dysfunction~* Normal serum potassium and calcium level~* No history of primary or secondary hyperparathyroidism~PRIOR CONCURRENT THERAPY:~* No prior EGFR pathway inhibitor

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).